Nair Vinay’s United Therapeutics UTHR Stock Holding History

Nair Vinay’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-2,042	Closed	-$352K	–	338
2015 Q1	$352K	Buy	+2,042	New	+$311K	0.25%	142

Other funds holding UTHR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

SCM

Scopia Capital Management New York $112M AUM 48.41% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 39.77% 1-Year Est. Return

Nair Vinay's UTHR Position: Q2 2015 in Review

Nair Vinay sold out of United Therapeutics (UTHR) in Q2 2015, closing a stake of 2,042 shares — an estimated $352K sold.

Nair Vinay first reported a position in UTHR in Q1 2015 and held it in 1 quarter. The position peaked at $352K in Q1 2015. 384 funds tracked by Wall St. Rank hold UTHR as of Q2 2015.

Nair Vinay reported no remaining United Therapeutics position as of Q2 2015 after selling out during the quarter.
Nair Vinay sold 2,042 United Therapeutics shares in Q2 2015, an estimated $352K.
Nair Vinay first reported a position in United Therapeutics in Q1 2015 and held it in 1 quarter.
Nair Vinay's United Therapeutics position peaked at $352K in Q1 2015.
384 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2015.

Based on Nair Vinay's 13F filing for Q2 2015, filed 12 Aug 2015.